Chooses subgroup specific optimal doses in a phase I dose finding clinical trial allowing for subgroup combination and simulates clinical trials under the subgroup specific time to event continual reassessment method. Chapple, A.G., Thall, P.F. (2018) <doi:10.1002/pst.1891>.
| Version: | 3.0.2 |
| Imports: | Rcpp (≥ 0.12.18) |
| LinkingTo: | Rcpp, RcppArmadillo |
| Published: | 2020-07-02 |
| Author: | Andrew Chapple |
| Maintainer: | Andrew Chapple <achapp at lsuhsc.edu> |
| License: | GPL-2 |
| NeedsCompilation: | yes |
| Materials: | README |
| CRAN checks: | SubTite results |
| Reference manual: | SubTite.pdf |
| Package source: | SubTite_3.0.2.tar.gz |
| Windows binaries: | r-devel: SubTite_3.0.2.zip, r-release: SubTite_3.0.2.zip, r-oldrel: SubTite_3.0.2.zip |
| macOS binaries: | r-release: SubTite_3.0.2.tgz, r-oldrel: SubTite_3.0.2.tgz |
| Old sources: | SubTite archive |
Please use the canonical form https://CRAN.R-project.org/package=SubTite to link to this page.